Drug interaction study of pelabresib in healthy adults
Treatments studied
This study tests how two other drugs affect the levels of the study drug pelabresib in healthy people. It aims to see if taking these drugs together changes how the body processes pelabresib.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 18 and 55 years old
- Be in good overall health
- Have a body mass index (BMI) between 18.5 and 29.9
- Weigh at least 50 kg
- Not have significant heart, liver, kidney, stomach, or nerve disease
- Not have had cancer (other than certain skin or cervical cancers) in the last 5 years
- For women: not be pregnant or planning to become pregnant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks if taking itraconazole, an antifungal medicine, changes how the body processes the investigational drug HS-10504. It helps researchers understand safe dosing and potential side effects.
This trial tests a new drug called Lu AH69593 in healthy volunteers to see how safe it is and how the body handles it. Participation involves staying at the clinic for a while and requires a health check.
This study tests how a drug called leramistat interacts with other medicines. It's for healthy adults who cannot get pregnant or make someone pregnant.
This study tests how a new experimental drug (BGB-58067) moves through your body and how two common medications affect that process. Researchers need healthy volunteers to understand if these drug interactions are safe.
This study tests how another drug (carbamazepine) affects the amount of an investigational drug (verducatib) in the blood of healthy men. It helps determine if the drugs can be given together safely and how they interact.
This study tests how a common antifungal medication (itraconazole) affects how the body processes an experimental drug called nacresertib. Researchers want to understand if taking both drugs together is safe and how they interact in healthy volunteers.
Hear when a new Healthy Participants trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.